The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.
MDMA therapy for PTSD treatment? FDA panel says no
Credits
Guest:
- Josh Hardman - editor and founder of Psychedelic Alpha